Share


Paliperidone is an antipsychotic medication used to treat certain mental health conditions. It is the active metabolite of risperidone and belongs to the class of atypical (second-generation) antipsychotics. In clinical care, paliperidone is often used to stabilize mood and thoughts, reduce psychotic symptoms, and help prevent relapse in some conditions. Like any medicine, its benefits and risks depend on the individual person, the condition being treated, and how the drug is used (oral tablets vs. long-acting injections).

How paliperidone works

Person with pill bottles and a dosing chart, paliperidone uses, side effects, and schizophrenia.

Paliperidone primarily blocks dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. This receptor activity is thought to help lessen positive symptoms of psychosis, such as hallucinations and delusions, and may also have effects on mood and cognition. In addition to these targets, paliperidone interacts with other receptor systems (including alpha-adrenergic and histamine receptors), which can influence side effects like sedation, blood pressure changes, and weight gain. A hallmark of paliperidone’s action is its blockade of dopamine signaling in pathways where overactivity contributes to psychotic symptoms, balanced by a profile that attempts to minimize some motor side effects seen with older antipsychotics.

Common uses and conditions treated

In the United States, paliperidone tablets and extended-release tablets are approved for the treatment of schizophrenia and schizoaffective disorder. The long-acting injectable forms are used primarily for adults with schizophrenia to improve treatment adherence and reduce relapse risk. Clinicians may consider paliperidone as part of a broader treatment plan that includes psychotherapy, social support, and education about the illness.

While paliperidone is not typically approved for routine treatment of bipolar disorder, some clinicians may use it off-label for certain bipolar symptoms based on individual patient needs and prior response to antipsychotic therapy. As with any medication outside its approved indications, this should be guided by a careful discussion of risks, benefits, and alternatives.

Typical dosages and forms

Paliperidone is available in several forms, including oral extended-release tablets and long-acting injectable formulations. Dosing is individualized based on the condition being treated, previous response, tolerability, and other medical factors. The following provides general, non-prescriptive guidelines and is not a substitute for a clinician’s instructions.

  • Oral extended-release (ER) tablets for adults with schizophrenia or schizoaffective disorder:
    • Starting dose commonly around 6 mg once daily.
    • Typical dose range: 3–12 mg once daily, adjusted by your clinician.
    • Maximum recommended daily dose: 12 mg.
    • In elderly patients or those with reduced kidney function, a lower starting dose and slower titration may be used.
  • Long-acting injectable paliperidone palmitate (for schizophrenia):
    • Invega Sustenna (monthly injections): Day 1 loading dose 234 mg, Day 8 dose of 156 mg, then 234 mg every 4 weeks (monthly) thereafter.
    • Invega Trinza (every 3 months): 273 mg every 3 months after at least 4 months of receiving Invega Sustenna and achieving stabilization.
    • These injections are administered by a healthcare professional in a clinical setting.

For any form, follow the dosing plan provided by your clinician. Do not adjust dose or switch formulations without medical advice. If you miss a dose of an injectable, your clinician will provide instructions on how to proceed.

Potential side effects and monitoring

All medicines can cause side effects. Paliperidone’s effects vary among individuals. Common and important considerations include:

Common side effects

  • Weight gain and metabolic changes (glucose, lipids)
  • Increased prolactin levels leading to menstrual changes, dizziness, sexual side effects, or breast changes
  • EPS-related symptoms such as tremor, stiffness, or restlessness (akathisia)
  • Drowsiness, fatigue, or sedation
  • Constipation, nausea, or stomach upset
  • Headache and dry mouth

Less common but important risks

  • Orthostatic hypotension (lightheadedness when standing)
  • Metabolic syndrome risk (weight, blood sugar, and lipid changes)
  • Hyperprolactinemia symptoms as noted above
  • Rare but serious conditions such as neuroleptic malignant syndrome or tardive dyskinesia
  • QT interval prolongation (heart rhythm changes) in some people, especially when combined with other QT-prolonging meds

Monitoring while on paliperidone

  • Regular weight checks and measurements of waist circumference
  • Periodic blood tests to monitor blood sugar, cholesterol, and prolactin levels, as advised by your clinician
  • Blood pressure, heart rate, and signs of EPS at follow-up visits
  • Kidney function, since paliperidone is cleared by the kidneys
  • Assessments of mood, cognition, and overall functioning to gauge effectiveness and tolerability
  • Pregnancy testing if applicable; discuss breastfeeding and newborn safety with your healthcare provider

Tell your clinician promptly about any concerning side effects, especially persistent dizziness, fainting, significant movement changes, breast or nipple discharge, or prolonged sleepiness.

Interactions with other medications

Paliperidone can interact with other medicines, potentially altering effects or increasing side effects. Important considerations include:

  • QT prolongation risk: Avoid or monitor closely if taking other drugs that can prolong the QT interval (such as certain antiarrhythmics, antibiotics, or antipsychotics). Electrolyte disturbances (low potassium or magnesium) can worsen this risk.
  • CNS depressants: Combining with alcohol, sedatives, or other central nervous system depressants can increase drowsiness or impair thinking and reaction time.
  • Dopamine-related meds: Coexisting Dopaminergic or anti-Parkinson medications may interact in ways that affect symptom control.
  • Renal function and other drugs cleared by the kidneys: Because paliperidone is primarily excreted through the kidneys, medications that affect kidney function or hydration status can influence drug levels.
  • Minimal involvement with cytochrome P450 enzymes: Paliperidone is not heavily metabolized by these enzymes, so many CYP-mediated interactions are less likely, but always review medications with your clinician and pharmacist.

Always tell your healthcare provider about all medicines you take, including over-the-counter drugs, vitamins, and herbal supplements. Do not start or stop medications without consulting your clinician, especially if you are on paliperidone.

Important considerations for patients

  • Pregnancy and breastfeeding: Paliperidone may pose risks to a fetus or nursing infant. Pregnancy should be planned and discussed with a clinician. Women who are pregnant or planning pregnancy should discuss potential benefits and risks with their healthcare provider. If you become pregnant while taking paliperidone, contact your clinician promptly.
  • Driving and daily activities: Paliperidone can cause drowsiness or dizziness in some people. Assess your own reaction before driving or operating machinery, especially after starting the medication or changing the dose.
  • Adherence and formulation choices: For some patients, a long-acting injectable can improve adherence and reduce relapse risk. The injections are given by a clinician, and the schedule (monthly or every 3 months) will be set by your treatment team.
  • Lifestyle and metabolic health: Regular exercise, a balanced diet, and routine screening for blood sugar and lipids can help manage potential metabolic side effects. Your clinician may recommend a plan tailored to you.
  • Renal considerations: Dose adjustments may be necessary in people with kidney impairment. Regular kidney function tests may be advised.
  • Communication with your care team: Keep a written list of all medications you take and share it with every healthcare provider you see. Report new symptoms, mood changes, or concerns promptly.
  • Cost and access: Availability of brand-name and generic formulations can vary by region. Talk with your pharmacist or insurer about coverage and alternatives if cost is a concern.

For additional information and patient-focused guidance, consider consulting reliable health information resources. Examples include:

If you have questions about paliperidone or want to know whether it might be appropriate for you or a loved one, talk with a psychiatrist, primary care clinician, or pharmacist. They can explain how paliperidone fits into your overall treatment plan, discuss expected benefits, manage side effects, and tailor dosing to your health profile.

Page Contents